Cancer stem cells: a new framework for the design of tumor therapies.
about
Cancer Stem Cells in Human Gastrointestinal CancerA new prospect in cancer therapy: targeting cancer stem cells to eradicate cancerCD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.Isolation and assessment of the in vitro anti-tumor activity of smenothiazole A and B, chlorinated thiazole-containing peptide/polyketides from the Caribbean sponge, Smenospongia aureaMB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-propertiesBlockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell LinesHigh frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.Clinical trial design for testing the stem cell model for the prevention and treatment of cancer.Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.Stemness in human thyroid cancers and derived cell lines: the role of asymmetrically dividing cancer stem cells resistant to chemotherapy.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.Clinical implication of targeting of cancer stem cells.Therapy-induced enrichment of putative lung cancer stem-like cells.Lung cancer stem cells and implications for future therapeutics.Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment.Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma.The cancer stem cell hypothesis: a guide to potential molecular targets.Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.MicroRNA-142-5p induces cancer stem cell-like properties of Cutaneous Squamous Cell Carcinoma via inhibiting PTEN.Implications of Oxygen Homeostasis for Tumor Biology and Treatment.STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.Tracking of mouse breast cancer stem-like cells with Salmonella.Cancer Stem Cells and Pediatric Solid Tumors.Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma.Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.Cancer Stem Cell Metabolism and Potential Therapeutic Targets.Stroma-derived IL-6, G-CSF and Activin-A mediated dedifferentiation of lung carcinoma cells into cancer stem cells
P2860
Q26737714-87263497-E541-43F3-B12C-1304ABA7CB2BQ27022134-877E0419-056C-4D68-A684-3C9138B02AA3Q34533871-AB122A77-B6E1-4442-9270-A4D3F9FA2884Q35015377-DD7ED56C-3343-4265-BC10-3EE80D1829A2Q35925281-1FFD07CD-5374-4C12-BBD6-085F932C2FDEQ35946125-8DC84C96-3994-4DCB-9E74-A2149DE13EB5Q36791997-3CAAF042-9396-4699-A948-3EF47F916EE2Q37132809-D3F2AB43-0293-42B0-9649-1F840013C75FQ37316834-5FB515D8-2F78-4308-BE0F-774BE26043C9Q37616850-C04CBA14-5600-4E92-B79A-CA35D5B23FD4Q38023238-A26B493E-C95B-47E5-9F80-B0C7F51B32B3Q38026464-938159A9-8778-4CB1-B0F1-5189AE0E316EQ38150766-70DEF2DB-32FF-495C-AC8B-CD8FC802E7F4Q38189297-8F0A8468-6260-4F41-8831-17F51F0E2D16Q38222758-E37D7016-89EA-4FB2-82B3-741BE05AA974Q38249887-A0549C2B-E920-4A24-83FC-1EC7D04D16F3Q38254181-7275E0F5-EF28-421F-957B-F7B58B3252EAQ38383345-2A2C7DBF-9BBE-4225-99BA-4C524DA2B359Q38600615-69A4F876-68C9-41CA-925A-528F799D00BFQ38876568-24D9A820-ECCE-43C9-B499-A81A8832E370Q38988872-71429EF6-FF96-4366-B136-825305384FFDQ39263845-B05F5116-7CC2-4131-B23E-55BEB0C3B39FQ39773200-2D375ABF-3625-4C80-8C1C-5F1F4D4297E5Q47144270-F2127B8E-90B3-4DFE-B033-AD3B77AA0373Q47150215-E1068930-205C-4691-8CB7-0F0FD76A6A40Q47678098-63C0EE04-F8D0-436E-8715-CC48EDDB4364Q47834312-ADABE467-C0BB-43B4-A40F-2DB11E8C4823Q55296899-07DCB560-5E37-46D5-A18D-28BC1310DE5FQ57970402-723DA486-2684-4D6D-A7F5-25C2507E1F59
P2860
Cancer stem cells: a new framework for the design of tumor therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer stem cells: a new framework for the design of tumor therapies.
@en
Cancer stem cells: a new framework for the design of tumor therapies.
@nl
type
label
Cancer stem cells: a new framework for the design of tumor therapies.
@en
Cancer stem cells: a new framework for the design of tumor therapies.
@nl
prefLabel
Cancer stem cells: a new framework for the design of tumor therapies.
@en
Cancer stem cells: a new framework for the design of tumor therapies.
@nl
P2860
P1476
Cancer stem cells: a new framework for the design of tumor therapies
@en
P2093
Boyan K Garvalov
Till Acker
P2860
P2888
P304
P356
10.1007/S00109-010-0685-3
P577
2010-10-02T00:00:00Z